Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pronase for improving visibility and safety in colonoscopy
ChiCTR2300071702Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of pronase in colorectal cancer (CRC), colonic polyp, inflammatory bowel disease (IBD) and 2 more (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Visual field clarity during colonoscopy. Planned start May 2023; status: not yet recruiting.
02
Drugs
pronase
03
Conditions
colorectal cancer (CRC)colonic polypinflammatory bowel disease (IBD)diarrheaconstipation
Beyond the preview
Go deeper on ChiCTR2300071702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071702.